Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-098944

Director sold 20,700 shares at an average $49.71 ($1,028,991)

  • Director acquired 20,700 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TETRAULT LYNN A. Director 2024-09-09 Option exercise 10b5-1 +3,199 $18.99 $60,749 6,199 D
TETRAULT LYNN A. Director 2024-09-09 Sale 10b5-1 −3,199 $50.04 $160,068 3,000 D
TETRAULT LYNN A. Director 2024-09-10 Option exercise 10b5-1 +10,000 $4.15 $41,500 13,000 D
TETRAULT LYNN A. Director 2024-09-10 Option exercise 10b5-1 +7,501 $18.99 $142,444 20,501 D
TETRAULT LYNN A. Director 2024-09-10 Sale 10b5-1 −8,490 $49.05 $416,418 12,011 D
TETRAULT LYNN A. Director 2024-09-10 Sale 10b5-1 −8,661 $50.20 $434,796 3,350 D
TETRAULT LYNN A. Director 2024-09-10 Sale 10b5-1 −350 $50.60 $17,710 3,000 D
Derivatives
TETRAULT LYNN A. Director 2024-09-09 Option exercise · Stock Option (right to buy) 10b5-1 −3,199 7,501 D
TETRAULT LYNN A. Director 2024-09-10 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 0 D
TETRAULT LYNN A. Director 2024-09-10 Option exercise · Stock Option (right to buy) 10b5-1 −7,501 0 D
Open-market sales · 20,700 sh · avg $49.71 · $1,028,991
Loading xslF345X05/tm2423816-2_4seq1.xml…